In silico prediction of ROCK II inhibitors by different classification approaches

Mol Divers. 2017 Nov;21(4):791-807. doi: 10.1007/s11030-017-9772-5. Epub 2017 Aug 2.

Abstract

ROCK II is an important pharmacological target linked to central nervous system disorders such as Alzheimer's disease. The purpose of this research is to generate ROCK II inhibitor prediction models by machine learning approaches. Firstly, four sets of descriptors were calculated with MOE 2010 and PaDEL-Descriptor, and optimized by F-score and linear forward selection methods. In addition, four classification algorithms were used to initially build 16 classifiers with k-nearest neighbors [Formula: see text], naïve Bayes, Random forest, and support vector machine. Furthermore, three sets of structural fingerprint descriptors were introduced to enhance the predictive capacity of classifiers, which were assessed with fivefold cross-validation, test set validation and external test set validation. The best two models, MFK + MACCS and MLR + SubFP, have both MCC values of 0.925 for external test set. After that, a privileged substructure analysis was performed to reveal common chemical features of ROCK II inhibitors. Finally, binding modes were analyzed to identify relationships between molecular descriptors and activity, while main interactions were revealed by comparing the docking interaction of the most potent and the weakest ROCK II inhibitors. To the best of our knowledge, this is the first report on ROCK II inhibitors utilizing machine learning approaches that provides a new method for discovering novel ROCK II inhibitors.

Keywords: Classification model; Docking; Kinase; Machine learning; Privileged substructures; ROCK II inhibitors.

MeSH terms

  • Computer Simulation*
  • Drug Discovery
  • Molecular Docking Simulation
  • Protein Conformation
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / metabolism
  • Protein Kinase Inhibitors / pharmacology*
  • rho-Associated Kinases / antagonists & inhibitors*
  • rho-Associated Kinases / chemistry
  • rho-Associated Kinases / metabolism

Substances

  • Protein Kinase Inhibitors
  • rho-Associated Kinases